Metraipolis › archive › dc_ad8a77987366

SLAMF7 promotes TCRαβ+ double negative T cell antitumor activity through enhancing glutamine metabolism — Europe PMC PMID:41168829

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41168829
DOI: 10.1186/s13046-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-11-08T22:56:19.675Z
SHA-256 of the archived text: 939debb3e5439574b698bbed047da3f6a9d65cdd67a7c21e0cfdb6f565a78878
Stable URL of this page: https://metraipolis.com/documento/dc_ad8a77987366

How to cite

SLAMF7 promotes TCRαβ+ double negative T cell antitumor activity through enhancing glutamine metabolism — Europe PMC PMID:41168829 — Europe PMC (en), https://europepmc.org/article/MED/41168829 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad8a77987366 (Metraipolis archive dc_ad8a77987366, sha256 939debb3e5439574b698bbed047da3f6a9d65cdd67a7c21e0cfdb6f565a78878)

BibTeX

@misc{dcad8a77987366,
  title = {SLAMF7 promotes TCRαβ+ double negative T cell antitumor activity through enhancing glutamine metabolism — Europe PMC PMID:41168829},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41168829},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad8a77987366; sha256 939debb3e5439574b698bbed047da3f6a9d65cdd67a7c21e0cfdb6f565a78878},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41168829. Agents can read the archived copy with the MCP tool read_document.